Clik here to view.
PHC推出LiCellMoTM活细胞代谢分析仪，用于细胞和基因治疗中细胞代谢的实时可视化
东京 (美国商业资讯)– PHC Corporation生物医学事业部（总部：东京都千代田区，总裁：Nobuaki...
View ArticleClik here to view.
LUCA Science Publishes Groundbreaking Research in Nature Metabolism:...
TOKYO LUCA Science Inc., in collaboration with Osaka University and Washington University School of Medicine in St. Louis, announces the publication of a transformative study in Nature Metabolism...
View ArticleClik here to view.
JCR Pharmaceuticals’ Data Presentations at SSIEM Annual Symposium 2024...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE: 4552) made significant contributions at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024, held in Porto,...
View ArticleClik here to view.
MedTech Innovator Asia Pacific Names APrevent Top 2024 Innovator in Grand...
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the...
View ArticleClik here to view.
New Analysis Demonstrates Impaired Work Productivity and Increased...
GALASHIELS, Scotland & MARLOW, England Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin) and a Japan-based global specialty...
View ArticleClik here to view.
First of its Kind Colorectal Cancer Data from Prospective GALAXY Study...
AUSTIN, Texas Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that new data from the GALAXY arm of the ongoing CIRCULATE-Japan trial was released today...
View ArticleClik here to view.
Data from a Phase 1 Trial of HighField Biopharmaceuticals’ HF1K16 Show the...
HANGZHOU, China HighField Biopharmaceuticals, a clinical stage company using lipid-based therapeutics to treat cancer, diabetes and other diseases, announced today its CEO and Scientific Founder...
View ArticleClik here to view.
GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer...
PALO ALTO, Calif. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the peer-reviewed journal Nature Medicine published results from the SCRUM-Japan GOZILA...
View ArticleClik here to view.
PHC、細胞の代謝変化をリアルタイムに可視化するライブセル代謝分析装置「LiCellMoTM（リセルモ）」を発売
東京 （ビジネスワイヤ） — PHC株式会社 バイオメディカ事業部（本社：東京都千代田区、代表取締役社長：中村...
View ArticleClik here to view.
Aurion Biotech在日本推出用于治疗大疱性角膜病变的Vyznova® (neltependocel)
西雅图、马萨诸塞州剑桥和东京 (美国商业资讯)– Aurion Biotech的使命是通过改变人生的再生疗法恢复数百万患者的视力，公司今天宣布开始在日本市售用于治疗大疱性角膜病变的Vyznova®（通用名称：neltependocel）。公司相信，这是第一种获批用于治疗角膜内皮疾病的细胞疗法；它已在日本获得监管和报销批准。伴随此次商业发布，日本京都府立医科大学(KPUM)的Shigeru...
View ArticleClik here to view.
Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment...
SEATTLE & CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced the commercial launch...
View ArticleClik here to view.
Promega Engineers New Enzyme to Significantly Reduce Stutter in Forensic DNA...
MADISON, Wis. A novel enzyme developed by research scientists at Promega Corporation will virtually eliminate confounding stutter artifacts in forensic DNA analysis. The reduced stutter polymerase...
View ArticleClik here to view.
SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide...
RANCHO CORDOVA, Calif. SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and peptide production capabilities...
View ArticleClik here to view.
SKファームテコ、小分子およびペプチドのグローバル生産を拡大すべく2億6,000万ドルを投資
カリフォルニア州ランチョコルドバ （ビジネスワイヤ） — 世界的な医薬品開発・製造受託機関（CDMO）であるSKファームテコは、2億6,000万ドルの投資を通じて韓国の世宗（セジョン）に最新鋭の施設を新設し、小分子およびペプチドの生産能力を大幅に拡大すると発表しました。...
View ArticleClik here to view.
Modalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to...
TOKYO & WALTHAM, Mass. Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita), a leading company pioneering treatments for rare genetic diseases using its proprietary...
View ArticleClik here to view.
KalVista Announces the Submission of Additional Marketing Authorization...
CAMBRIDGE, Mass. & SALISBURY, England KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced Marketing Authorization Application (MAA) submissions to the regulatory authorities in the...
View ArticleClik here to view.
PHC、独自のIn-Lineモニタリング技術を活用した自動培養装置「LiCellGrow」のプロトタイプを「再生医療JAPAN 2024」に出展
東京 （ビジネスワイヤ） — PHC株式会社 バイオメディカ事業部（本社：東京都千代田区、代表取締役社長：中村 伸朗、以下「バイオメディカ事業部」）は、10月9日（水）から10月11日（金）までパシフィコ横浜で開催される「再生医療JAPAN...
View ArticleClik here to view.
Global Healthy Living Foundation Partners with The Bone Bus to Enhance Rural...
UPPER NYACK, N.Y. & SYDNEY The Global Healthy Living Foundation Australia (GHLF Australia) is proud to announce its collaboration with The Bone Bus, an Australian traveling bone density...
View ArticleClik here to view.
Ferring Pharmaceuticals bolsters global gene therapy supply chain with...
SAINT-PREX, Switzerland Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene...
View ArticleClik here to view.
Lifebit and Flatiron Health Bring Cutting-Edge Research Technology to Japan,...
TOKYO Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by...
View Article